Image Sourced LinkedIn
Market Herald logo


Be the first with the news that moves the market

Dr John Lambert was recently appointed as Chief Executive Officer of pharmaceutical company Amplia Therapeutics in June of 2019.

Prior to this role he worked as Amplia’s Operations Manager since August 2018 and has been directing all aspects on the enabling work since then.

When asked about the appointment Chairman of Amplia Dr Warwick Tong spoke highly of Dr Lambert.

“The appointment of Dr Lambert as Chief Executive is another important step in the transformation of Amplia,” he said.

“John’s experience and enthusiasm makes him the ideal candidate to deliver the near and medium clinical development milestones we have set for the Company.”

Based in Melbourne Dr Lambert has worked in the drug discovery and development sectors for over 20 years.

His experience spans over the full drug development lifecycle from early discovery, intellectual property protection, licensing, product development and regulatory approval.

Dr Lambert’s previous roles have included Drug Development, Operations Management and Drug Discovery at Biota Pharmaceuticals, Senior Director at Medicines Development for Global Health, and academic researcher in medicinal and biological chemistry at Harvard University and the University of Melbourne.

He is also an experienced manager in both early and late development of therapeutics and has built and led multiple project teams with the objective of delivering proof-of-concept for new products.

More From The Market Herald
Lucas Drilling (ASX:AJL) - CEO, Brett Tredinnick

" Brett Tredinnick, CEO of AJ Lucas Group Limited

A powerhouse within the energy industry, Brett Tredinnick is the CEO of Drilling Operations at AJ Lucas Group Limited.
Elementos (ASX:ELT) - Chairman, Andy Greig

" Elementos (ASX:ELT) CEO Chris Creagh steps down

Elementos (ASX:ELT) CEO Chris Creagh has stepped down from his position as part of a board…
LUCRF Super - CEO, Charlie Donnelly

" Charlie Donnelly, CEO of LUCRF Super

Putting the workers first was already in the lifeblood of CEO Charlie Donnelly long before taking…

" RareX (ASX:REE) appoints John Young as Non-Executive Chairman

Following an extensive search, RareX (ASX:REE) has appointed Mr John Young to the Board as Non-Executive…